Knee Osteoarthritis. Gonarthrosis
Conditions
Interventions
Intervention 1: In intervention group: patients will receive ostrich oil 1 cc production of MAM pharmaceutical company per knee two times in a day topically for 3 months. Intervention 2: In control gr
Treatment - Drugs
Placebo
In intervention group: patients will receive ostrich oil 1 cc production of MAM pharmaceutical company per knee two times in a day topically for 3 months.
In control group: patients will receive placebo 1 cc production of MAM pharmaceutical company per knee two times in a day topically for 3 months.
Sponsors
Vice chancellor for research, Tabriz University of Medical Sciences.
Eligibility
Sex/Gender
All
Age
45 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age between 45 to 60 years old; knee osteoarthritis based on clinical and radiological criteria; morning stiffness less than 10 minutes; moderate knee osteoarthritis based on radiological criteria; informed consent form for participating in study. Exclusion criteria: severe knee osteoarthritis; body mass index more than 30.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Knee joint pain. Timepoint: Beginig of study and 3 months later. Method of measurement: Physical examination based on WOMAC questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse effects. Timepoint: 3 months later. Method of measurement: Patient follow up. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Ali Asghar Ebrahimi
Tabriz University of Medical Sciences.
Outcome results
None listed